163 related articles for article (PubMed ID: 16434892)
1. Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance.
Kyzas PA; Stefanou D; Batistatou A; Agnantis NJ; Nakanishi Y; Hirohashi S; Charalabopoulos K
Am J Surg Pathol; 2006 Feb; 30(2):185-93. PubMed ID: 16434892
[TBL] [Abstract][Full Text] [Related]
2. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy.
Muramatsu H; Akimoto T; Maebayashi K; Kita M; Mitsuhashi N
Anticancer Res; 2008; 28(6B):3859-64. PubMed ID: 19192641
[TBL] [Abstract][Full Text] [Related]
4. Adhesion molecules in cancer of the head and neck: role of dysadherin.
Giotakis I; Chrysovergis A; Georgolios A; Giotakis E; Manolopoulos L
J BUON; 2011; 16(4):609-12. PubMed ID: 22331710
[TBL] [Abstract][Full Text] [Related]
5. Expression of dysadherin and cytokeratin as prognostic indicators of disease-free survival in patients with stage I NSCLC.
Ono K; Uramoto H; Hanagiri T
Anticancer Res; 2010 Sep; 30(9):3273-8. PubMed ID: 20944097
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of dysadherin expression in cervical squamous cell carcinoma.
Wu D; Qiao Y; Kristensen GB; Li S; Troen G; Holm R; Nesland JM; Suo Z
Pathol Oncol Res; 2004; 10(4):212-8. PubMed ID: 15619642
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.
Tamura M; Ohta Y; Tsunezuka Y; Matsumoto I; Kawakami K; Oda M; Watanabe G
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):740-5. PubMed ID: 16153922
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites.
Mitselou A; Batistatou A; Nakanishi Y; Hirohashi S; Vougiouklakis T; Charalabopoulos K
Histol Histopathol; 2010 Oct; 25(10):1257-67. PubMed ID: 20712010
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral lymphangiogenesis in oral squamous cell carcinoma and its clinicopathological significance.
Zhao D; Pan J; Li XQ; Wang XY; Tang C; Xuan M
J Oral Pathol Med; 2008 Nov; 37(10):616-25. PubMed ID: 19012622
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases.
Nakanishi Y; Akimoto S; Sato Y; Kanai Y; Sakamoto M; Hirohashi S
Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):323-8. PubMed ID: 15536331
[TBL] [Abstract][Full Text] [Related]
11. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion.
Maehata Y; Hirahashi M; Aishima S; Kishimoto J; Hirohashi S; Yao T; Takashima H; Tsuneyoshi M; Oda Y
Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of dysadherin expression in gastric cancer patients.
Shimada Y; Yamasaki S; Hashimoto Y; Ito T; Kawamura J; Soma T; Ino Y; Nakanishi Y; Sakamoto M; Hirohashi S; Imamura M
Clin Cancer Res; 2004 Apr; 10(8):2818-23. PubMed ID: 15102690
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of dysadherin expression in esophageal squamous cell carcinoma.
Shimada Y; Hashimoto Y; Kan T; Kawamura J; Okumura T; Soma T; Kondo K; Teratani N; Watanabe G; Ino Y; Sakamoto M; Hirohashi S; Imamura M
Oncology; 2004; 67(1):73-80. PubMed ID: 15459499
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
Nishizawa A; Nakanishi Y; Yoshimura K; Sasajima Y; Yamazaki N; Yamamoto A; Hanada K; Kanai Y; Hirohashi S
Cancer; 2005 Apr; 103(8):1693-700. PubMed ID: 15751018
[TBL] [Abstract][Full Text] [Related]
15. Dysadherin: expression and clinical significance in thyroid carcinoma.
Sato H; Ino Y; Miura A; Abe Y; Sakai H; Ito K; Hirohashi S
J Clin Endocrinol Metab; 2003 Sep; 88(9):4407-12. PubMed ID: 12970317
[TBL] [Abstract][Full Text] [Related]
16. Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma.
Batistatou A; Charalabopoulos AK; Scopa CD; Nakanishi Y; Kappas A; Hirohashi S; Agnantis NJ; Charalabopoulos K
Virchows Arch; 2006 Jun; 448(6):763-7. PubMed ID: 16570180
[TBL] [Abstract][Full Text] [Related]
17. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations.
Franchi A; Gallo O; Massi D; Baroni G; Santucci M
Cancer; 2004 Sep; 101(5):973-8. PubMed ID: 15329906
[TBL] [Abstract][Full Text] [Related]
18. Involvement of dysadherin and E-cadherin in the development of testicular tumours.
Batistatou A; Scopa CD; Ravazoula P; Nakanishi Y; Peschos D; Agnantis NJ; Hirohashi S; Charalabopoulos KA
Br J Cancer; 2005 Dec; 93(12):1382-7. PubMed ID: 16333245
[TBL] [Abstract][Full Text] [Related]
19. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression.
Shimamura T; Sakamoto M; Ino Y; Sato Y; Shimada K; Kosuge T; Sekihara H; Hirohashi S
J Clin Oncol; 2003 Feb; 21(4):659-67. PubMed ID: 12586803
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region.
Maula SM; Luukkaa M; Grénman R; Jackson D; Jalkanen S; Ristamäki R
Cancer Res; 2003 Apr; 63(8):1920-6. PubMed ID: 12702584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
